Any feedback?
Please rate this page
(enzyme.php)
(0/150)

BRENDA support

BRENDA Home
show all | hide all No of entries

Information on EC 3.2.1.114 - mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase and Organism(s) Drosophila melanogaster and UniProt Accession Q24451

for references in articles please use BRENDA:EC3.2.1.114
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
EC Tree
IUBMB Comments
The enzyme, found in plants and animals, participates in the processing of N-glycans in the Golgi apparatus. It removes two mannosyl residues, one linked by alpha1,3 linkage, and the other linked by alpha1,6 linkage, both of which are removed by the same catalytic site. The enzyme is sensitive to swainsonine.
Specify your search results
Select one or more organisms in this record: ?
This record set is specific for:
Drosophila melanogaster
UNIPROT: Q24451
Show additional data
Do not include text mining results
Include (text mining) results
Include results (AMENDA + additional results, but less precise)
Word Map
The taxonomic range for the selected organisms is: Drosophila melanogaster
The expected taxonomic range for this enzyme is: Eukaryota, Bacteria
Synonyms
mannosidase ii, jack bean alpha-mannosidase, man2a1, alpha-mannosidase iix, dgmii, manii, alpha-mii, drosophila gmii, alpha-d-mannosidase ii, afams1, more
SYNONYM
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
alpha-mannosidase
-
glycoside hydrolase
-
alpha-D-mannosidase II
-
-
-
-
alpha-mannosidase II
alpha-mannosidase III
-
-
-
-
alpha1-3,6-mannosidase
-
-
-
-
exo-1,3-1,6-alpha-mannosidase
-
-
-
-
GH38 Golgi alpha-mannosidase II
-
-
GlcNAc transferase I-dependent alpha1,3[alpha1,6]mannosidase
-
-
-
-
Golgi alpha-mannosidase II
Man II
-
-
-
-
MAN IIx
-
-
-
-
ManIII
-
-
-
-
mannose-trimming enzyme
-
-
mannosidase II
-
-
-
-
mannosidase, exo-1,3-1,6-alpha-
-
-
-
-
mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase
-
-
-
-
mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase II
-
-
additional information
REACTION
REACTION DIAGRAM
COMMENTARY hide
ORGANISM
UNIPROT
LITERATURE
Man5GlcNAc3-[protein] + 2 H2O = Man3GlcNAc3-[protein] + 2 alpha-D-mannopyranose
show the reaction diagram
Man5GlcNAc3-[protein] + 2 H2O = Man3GlcNAc3-[protein] + 2 alpha-D-mannopyranose
show the reaction diagram
catalytic mechanism
-
REACTION TYPE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
hydrolysis of O-glycosyl bond
-
hydrolysis of O-glycosyl bond
-
-
-
-
hydrolysis of N-glycosyl bond
-
PATHWAY SOURCE
PATHWAYS
-
-, -
SYSTEMATIC NAME
IUBMB Comments
(1->3)-(1->6)-mannosyl-oligosaccharide alpha-D-mannohydrolase (configuration-retaining)
The enzyme, found in plants and animals, participates in the processing of N-glycans in the Golgi apparatus. It removes two mannosyl residues, one linked by alpha1,3 linkage, and the other linked by alpha1,6 linkage, both of which are removed by the same catalytic site. The enzyme is sensitive to swainsonine.
CAS REGISTRY NUMBER
COMMENTARY hide
349553-33-9
alpha-mannosidase III
82047-77-6
alpha-mannosidase II
SUBSTRATE
PRODUCT                       
REACTION DIAGRAM
ORGANISM
UNIPROT
COMMENTARY
(Substrate) hide
LITERATURE
(Substrate)
COMMENTARY
(Product) hide
LITERATURE
(Product)
Reversibility
r=reversible
ir=irreversible
?=not specified
2,4-dinitrophenyl alpha-D-mannoside + H2O
2,4-dinitrophenol + alpha-D-mannose
show the reaction diagram
-
-
?
2,4-dinitrophenyl-alpha-D-mannopyranoside + H2O
2,4-dinitrophenol + D-mannose
show the reaction diagram
-
-
-
?
2,5-dinitrophenyl-alpha-D-mannopyranoside + H2O
2,5-dinitrophenol + alpha-D-mannose
show the reaction diagram
pH 5.6, room temperature
-
-
?
2,5-dinitrophenyl-alpha-D-mannopyranoside + H2O
2,5-dinitrophenol + D-mannose
show the reaction diagram
-
-
-
?
2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1->2)-alpha-D-mannopyranosyl-(1->3)-[alpha-D-mannopyranosyl-(1->3)-alpha-D-mannopyranosyl-(1->6)]-beta-D-mannopyranosyl-(1->4)-2-(acetylamino)-2-deoxy-alpha-D-glucopyranose + H2O
2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1->2)-alpha-D-mannopyranosyl-(1->3)-[alpha-D-mannopyranosyl-(1->6)]-beta-D-mannopyranosyl-(1->4)-2-(acetylamino)-2-deoxy-alpha-D-glucopyranose + D-mannose
show the reaction diagram
-
-
-
ir
2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1->2)-alpha-D-mannopyranosyl-(1->3)-[alpha-D-mannopyranosyl-(1->3)-[alpha-D-mannopyranosyl-(1->6)]-alpha-D-mannopyranosyl-(1->6)]-beta-D-mannopyranosyl-(1->4)-2-(acetylamino)-2-deoxy-alpha-D-glucopyranose + H2O
2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1->2)-alpha-D-mannopyranosyl-(1->3)-[alpha-D-mannopyranosyl-(1->3)-alpha-D-mannopyranosyl-(1->6)]-beta-D-mannopyranosyl-(1->4)-2-(acetylamino)-2-deoxy-alpha-D-glucopyranose + D-mannose
show the reaction diagram
-
-
-
ir
2-deoxy-2-fluoro-alpha-D-mannosyl fluoride
?
show the reaction diagram
wild-type and D341N mutant GMII, acts as very slow substrate of the mutant enzyme with a rate-limiting deglycosylation step
-
-
?
4-nitrophenyl alpha-D-mannoside + H2O
4-nitrophenol + alpha-D-mannose
show the reaction diagram
-
-
-
?
5-fluoro-beta-L-gulosyl fluoride + H2O
?
show the reaction diagram
acts as slow substrate with a rate-limiting deglycosylation step, wild-type and D341N mutant GMII
-
-
?
GlcNAcMan5GlcNAc2 + H2O
? + alpha-D-mannose
show the reaction diagram
-
-
-
?
2,4-dinitrophenyl alpha-D-mannopyranoside + H2O
?
show the reaction diagram
-
-
-
?
4-methylumbelliferyl alpha-D-mannopyranoside + H2O
?
show the reaction diagram
-
-
-
?
4-methylumbelliferyl alpha-D-mannoside + H2O
4-methylumbelliferol + alpha-D-mannose
show the reaction diagram
-
-
-
-
?
4-methylumbelliferyl alpha-D-mannoside + H2O
4-methylumbelliferone + alpha-D-mannose
show the reaction diagram
-
-
-
?
4-nitrophenyl alpha-D-mannoside + H2O
4-nitrophenol + alpha-D-mannose
show the reaction diagram
-
-
-
-
?
4-nitrophenyl-alpha-D-mannopyranoside + H2O
4-nitrophenol + alpha-D-mannose
show the reaction diagram
30 min, 20°C
-
-
?
Manalpha(1-6)[Manalpha(1-3)]Manalpha(1-6)[GlcNAcbeta(1-2)Manalpha(1-3)]Manbeta(1-4)GlcNAcbeta(1-4)GlcNAc + 2 H2O
Manalpha(1-6)[GlcNAcbeta(1-2)Manalpha(1-3)]Manbeta(1-4)GlcNAcbeta(1-4)GlcNAc + 2 alpha-D-mannose
show the reaction diagram
-
N-glycosylation pathway
-
?
additional information
?
-
NATURAL SUBSTRATE
NATURAL PRODUCT
REACTION DIAGRAM
ORGANISM
UNIPROT
COMMENTARY
(Substrate) hide
LITERATURE
(Substrate)
COMMENTARY
(Product) hide
LITERATURE
(Product)
REVERSIBILITY
r=reversible
ir=irreversible
?=not specified
GlcNAcMan5GlcNAc2 + H2O
? + alpha-D-mannose
show the reaction diagram
-
-
-
?
4-methylumbelliferyl alpha-D-mannopyranoside + H2O
?
show the reaction diagram
-
-
-
?
Manalpha(1-6)[Manalpha(1-3)]Manalpha(1-6)[GlcNAcbeta(1-2)Manalpha(1-3)]Manbeta(1-4)GlcNAcbeta(1-4)GlcNAc + 2 H2O
Manalpha(1-6)[GlcNAcbeta(1-2)Manalpha(1-3)]Manbeta(1-4)GlcNAcbeta(1-4)GlcNAc + 2 alpha-D-mannose
show the reaction diagram
-
N-glycosylation pathway
-
?
additional information
?
-
METALS and IONS
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
INHIBITOR
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
(1R,2R,3R,4S,5R)-4-amino-5-methoxycyclopentane-1,2,3-triol
-
(1R,2R,3S,4R,5R)-5-aminocyclopentane-1,2,3,4-tetrol
-
(1R,2S,8aS)-1,2-dihydroxyoctahydrothieno[1,2-a]thiopyranium chloride
good inhibitor, lacks a hydroxyl group at C-5, more than 140fold better inhibitor of GMII than di-epi-swainsonine
(1S,2R,5R,8R,8aR)-5-[2-(4-tert-butylphenyl)ethyl]octahydroindolizine-1,2,8-triol
-
(1S,2R,5S,8R,8aR)-5-[2-(4-tert-butylphenyl)ethyl]octahydroindolizine-1,2,8-triol
-
(1S,2R,6R,7R,8S,8aS)-octahydroindolizine-1,2,6,7,8-pentol
most active
(1S,2R,8R,8aR)-octahydroindolizine-1,2,8-triol
-
(2R,3R,4R,5R)-2-(hydroxymethyl)piperidine-3,4,5-triol
-
(2R,3R,4R,5R)-5-amino-2-(hydroxymethyl)piperidine-3,4-diol
-
(2R,3R,4S)-2-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)pyrrolidine-3,4-diol
(2R,3R,4S)-2-([[(1S)-2-hydroxy-1-phenylethyl]amino]methyl)pyrrolidine-3,4-diol
-
(2R,3R,4S,5R)-2-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)-5-methylpyrrolidine-3,4-diol
-
(2R,3R,4S,5S)-6-amino-2-(hydroxymethyl)-2,3,4,5-tetrahydropyridine-3,4,5-triol
-
(2R,3S,4R)-2-[(1R)-1-hydroxyethyl]pyrrolidine-3,4-diol
most active
(2R,3S,4S)-1-[(2S,3S)-2,4-dihydroxy-3-(sulfooxy)butyl]-3,4-dihydroxy-2-(hydroxymethyl)tetrahydrothiophenium
-
(3R,4R)-4-aminopyrrolidin-3-ol
-
(3R,4R,5R)-3,4-dihydroxy-5-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)-1-methylpyrrolidin-2-one
-
(3R,4R,5R)-3,4-dihydroxy-5-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)pyrrolidin-2-one
-
(3S,4S,5R,6R,E)-3,4,5-trihydroxy-6-(hydroxymethyl)piperidin-2-one O-4-chlorophenylcarbamoyl oxime
-
(5R,6R,7S,8R)-5-methyl-1,5,6,7,8,8a-hexahydrotetrazolo[1,5-a]pyridine-6,7,8-triol
-
(5R,6R,7S,8S)-5-(hydroxymethyl)-1,5,6,7,8,8a-hexahydroimidazo[1,2-a]pyridine-6,7,8-triol
-
1-(4-methylphenyl)-2-[(1S,2R,5R,8R,8aR)-1,2,8-trihydroxyoctahydroindolizin-5-yl]ethanone
-
1-(4-tert-butylphenyl)-2-[(1S,2R,5R,8R,8aR)-1,2,8-trihydroxyoctahydroindolizin-5-yl]ethanone
-
1-(4-tert-butylphenyl)-2-[(1S,2R,5S,8R,8aR)-1,2,8-trihydroxyoctahydroindolizin-5-yl]ethanone
-
1-phenyl-2-[(1S,2R,5R,8R,8aR)-1,2,8-trihydroxyoctahydroindolizin-5-yl]ethanone
-
2-deoxy-2-fluoro-alpha-D-mannosyl fluoride
reversible, D341N mutant GMII
5-fluoro-beta-L-gulosyl fluoride
reversible, wild-type and D341N mutant GMII, inhibits only at low assay temperatures, acts as slow substrate at 37°C
5-thio-alpha-D-mannopyranosylamine
-
8-epi-lentiginosine
-
deoxymannojirimycin
-
di-epi-swainsonine
weak inhibitor
diastereomer of salacinol
-
diastereomer of seleno-salacinol
-
gluco-hydroxyiminolactam
-
Mannostatin A
N-octyl-6-epi-valienamine
-
N-[(R)-amino(phenyl)methyl]-5-thio-alpha-D-mannopyranosylamine
-
swainsonine
[[(3S,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)piperidin-2-ylidene]amino] N-(4-chlorophenyl)carbamate
-
(1R,2R,3R,4S,5R)-4-amino-5-methoxycyclopentane-1,2,3-triol
-
(1R,2S,3R,4R,5R)-5-aminocyclopentane-1,2,3,4-tetraol
-
(2S,3R,4S)-2-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)pyrrolidine-3,4-diol
-
(3R,4R,5S)-3,4-dihydroxy-5-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)-1-methylpyrrolidin-2-one
competitive inhibitor
(3R,4R,5S)-3,4-dihydroxy-5-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)pyrrolidin-2-one
competitve inhibitor
1-deoxyamino-cyclopentitetrol
-
-
1-deoxyaminocyclopentitetrol
1-deoxymannojirimycin
-
more inhibitory than kifunensine, mode of binding
deoxymannojirimycin
-
-
kifunensine
-
weak, mode of binding
Mannostatin A
mannostatin B
strong inhibitor, reversible, competitive
N-benzyl mannostatin A
-
structural basis of the inhibition of Golgi alpha-mannosidase II and the role of the thiomethyl moiety in ligand-protein interactions, overview
N-benzyl-mannostatin
-
-
swainsonine
additional information
-
KM VALUE [mM]
SUBSTRATE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
0.05 - 5.5
2,4-dinitrophenyl alpha-D-mannoside
25
2-deoxy-2-fluoro-alpha-D-mannosyl fluoride
pH 5.6, 37°C, above, wild-type GMII
0.2
5-fluoro-beta-L-gulosyl fluoride
pH 5.6, 37°C, wild-type GMII
TURNOVER NUMBER [1/s]
SUBSTRATE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
0.048 - 8.6
2,4-dinitrophenyl alpha-D-mannoside
0.0051
5-fluoro-beta-L-gulosyl fluoride
pH 5.6, 37°C, wild-type GMII
Ki VALUE [mM]
INHIBITOR
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
0.000076
(1R,2R,3R,4S,5R)-4-amino-5-methoxycyclopentane-1,2,3-triol
-
0.0003
(1R,2R,3S,4R,5R)-5-aminocyclopentane-1,2,3,4-tetrol
-
0.00002
(1S,2R,8R,8aR)-octahydroindolizine-1,2,8-triol
20C, pH 6.8
0.067
(2R,3R,4S)-2-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)pyrrolidine-3,4-diol
20C, pH 6.8
0.001
(3R,4R,5R)-3,4-dihydroxy-5-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)-1-methylpyrrolidin-2-one
20C, pH 6.8
0.022
(3R,4R,5R)-3,4-dihydroxy-5-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)pyrrolidin-2-one
20C, pH 6.8
0.52
(3S,4S,5R,6R,E)-3,4,5-trihydroxy-6-(hydroxymethyl)piperidin-2-one O-4-chlorophenylcarbamoyl oxime
-
0.0027
1-(4-methylphenyl)-2-[(1S,2R,5R,8R,8aR)-1,2,8-trihydroxyoctahydroindolizin-5-yl]ethanone
pH 5.75, 25°C
0.0027
1-(4-tert-butylphenyl)-2-[(1S,2R,5R,8R,8aR)-1,2,8-trihydroxyoctahydroindolizin-5-yl]ethanone
pH 5.75, 25°C
0.4
1-deoxymannojirimycin
-
0.0028
1-phenyl-2-[(1S,2R,5R,8R,8aR)-1,2,8-trihydroxyoctahydroindolizin-5-yl]ethanone
pH 5.75, 25°C
7.5
2-deoxy-2-fluoro-alpha-D-mannosyl fluoride
pH 5.6, 37°C, D341N mutant GMII
0.6
5-fluoro-beta-L-gulosyl fluoride
pH 5.6, 37°C, D341N mutant GMII
0.4
deoxymannojirimycin
pH 5.6
0.07
gluco-hydroxyiminolactam
0.013
glucoimidazole
5
kifunensine
pH 5.6
0.002
mannoimidazole
0.000036
Mannostatin A
-
0.00015
mannostatin B
-
0.017
N-octyl-6-epi-valienamine
0.02
noeuromycin
0.00002 - 0.003
swainsonine
0.52
[[(3S,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)piperidin-2-ylidene]amino] N-(4-chlorophenyl)carbamate
pH 5.6
0.000076
(1R,2R,3R,4S,5R)-4-amino-5-methoxycyclopentane-1,2,3-triol
-
0.0003
(1R,2S,3R,4R,5R)-5-aminocyclopentane-1,2,3,4-tetraol
-
0.067
(2S,3R,4S)-2-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)pyrrolidine-3,4-diol
-
0.001
(3R,4R,5S)-3,4-dihydroxy-5-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)-1-methylpyrrolidin-2-one
-
0.022
(3R,4R,5S)-3,4-dihydroxy-5-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)pyrrolidin-2-one
-
0.265
1-deoxyamino-cyclopentitetrol
-
-
0.265
1-deoxyaminocyclopentitetrol
5.2
kifunensine
-
pH 5.75, 37°C
0.000036
Mannostatin A
0.00015
mannostatin B
-
0.000249
N-benzyl mannostatin A
-
-
0.000249
N-benzyl-mannostatin
-
-
0.0000105 - 0.00002
swainsonine
additional information
additional information
although too weak for full Ki analyses with the amounts of material available, all analogues with salacinol-like stereochemistry at positions 2 and 3 proved to be weak inhibitors of the enzyme with IC50 values of approximately 7.5 mM
-
IC50 VALUE [mM]
INHIBITOR
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
0.00025
(1S,2R,5R,8R,8aR)-5-[2-(4-tert-butylphenyl)ethyl]octahydroindolizine-1,2,8-triol
Drosophila melanogaster
pH 5.75, 25°C
0.000044
(1S,2R,5S,8R,8aR)-5-[2-(4-tert-butylphenyl)ethyl]octahydroindolizine-1,2,8-triol
Drosophila melanogaster
pH 5.75, 25°C
0.8
(2R,3R,4S)-2-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)pyrrolidine-3,4-diol
Drosophila melanogaster
-
0.72
(2R,3R,4S)-2-([[(1S)-2-hydroxy-1-phenylethyl]amino]methyl)pyrrolidine-3,4-diol
Drosophila melanogaster
-
1
(2R,3R,4S,5R)-2-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)-5-methylpyrrolidine-3,4-diol
Drosophila melanogaster
-
0.000029
1-(4-methylphenyl)-2-[(1S,2R,5R,8R,8aR)-1,2,8-trihydroxyoctahydroindolizin-5-yl]ethanone
Drosophila melanogaster
pH 5.75, 25°C
0.000029
1-(4-tert-butylphenyl)-2-[(1S,2R,5R,8R,8aR)-1,2,8-trihydroxyoctahydroindolizin-5-yl]ethanone
Drosophila melanogaster
pH 5.75, 25°C
0.00025
1-(4-tert-butylphenyl)-2-[(1S,2R,5S,8R,8aR)-1,2,8-trihydroxyoctahydroindolizin-5-yl]ethanone
Drosophila melanogaster
pH 5.75, 25°C
0.00003
1-phenyl-2-[(1S,2R,5R,8R,8aR)-1,2,8-trihydroxyoctahydroindolizin-5-yl]ethanone
Drosophila melanogaster
pH 5.75, 25°C
0.014
8-epi-lentiginosine
Drosophila melanogaster
-
2
di-epi-swainsonine
Drosophila melanogaster
-
0.000017 - 0.000037
swainsonine
pH OPTIMUM
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
pH RANGE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
TEMPERATURE OPTIMUM
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
ORGANISM
COMMENTARY hide
LITERATURE
UNIPROT
SEQUENCE DB
SOURCE
SOURCE TISSUE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
SOURCE
UNIPROT
ENTRY NAME
ORGANISM
NO. OF AA
NO. OF TRANSM. HELICES
MOLECULAR WEIGHT[Da]
SOURCE
SEQUENCE
LOCALIZATION PREDICTION?
MAN2_DROME
1108
1
126721
Swiss-Prot
Secretory Pathway (Reliability: 1)
PDB
SCOP
CATH
UNIPROT
ORGANISM
MOLECULAR WEIGHT
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
120500
x * 120500, D341N mutant GMII
127000
x * 127000, predicted from the amino acid sequence
SUBUNIT
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
CRYSTALLIZATION (Commentary)
ORGANISM
UNIPROT
LITERATURE
by hanging-drop vapor diffusion method, GMII in complex with inhibitors di-epi-swainsonine and 8-epi-lentiginosine, both adopt a 3C6/E7 conformation, water molecule substructure in the active site plays a significant role in dictating inhibitory activity
enzyme with bound unhibitors, X-ray diffraction structure determination and analysis
GMII complexed with inhibitors (2R,3R,4S)-2-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)pyrrolidine-3,4-diol, (2R,3R,4S)-2-([[(1S)-2-hydroxy-1-phenylethyl]amino]methyl)pyrrolidine-3,4-diol, and (2R,3R,4S,5R)-2-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)-5-methylpyrrolidine-3,4-diol, to 1.30-1.45 A resolution
hanging drop vapor diffusion
in complex with inhibitor mannostatin A and its derivatives. The interaction with the backbone carbonyl of residue R876 is crucial to the high potency of the inhibitor and enhanced by the hydrophobic interaction between the thiomethyl group and an aromatic pocket vivinal to the cleavage site
in complex with inhibitors (3R,4R,5R)-3,4-dihydroxy-5-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)pyrrolidin-2-one and (3R,4R,5R)-3,4-dihydroxy-5-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)-1-methylpyrrolidin-2-one, to 1.08 A and 1.74 A resolution, respectively
in complex with inhibitors mannoimidazole, glucoimidazole, N-octyl-6-epi-valienamine, gluco-hydroxyiminolactam, and [[(3S,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)piperidin-2-ylidene]amino] N-(4-chlorophenyl)carbamate
in complex with natural substrate GlcNAcMan5GlcNAc2 and with oligosaccharide Man5. The natural substrate binds in a large groove on the surface of the enzyme. This groove contains the site of the nucleophile D204, acid/base catalyst D341, and zinc ion. substrate binding does not induce any noticeable conformational change. the larger active site cleft contains three sugar-binding subsites
mutants D204A and D341N in complex with 2,4-dinitrophenyl-alpha-D-mannopyranoside and in complex with oligosaccharides containing an alpha-(1,6)-or alpha-(1,3)-linked 1-thio-alpha-mannoside
wild-type and D341N mutant GMII, hanging drop vapor diffusion
crystal structure of enzyme with bound inhibitors kifunensine, swainsonine and 1-deoxymannojirimycin
-
enzyme in complex with inhibitors mannostatin A, N-benzyl mannostatin A, and 1-deoxyaminocyclopentitetrol, crystal growth overnight of enzyme solved in phosphate buffered reservoir solution, crystals are soaked for 3-6 h in 10 mM ligand solution, co-crystallization in Tris buffer without phosphate washing, X-ray diffraction structure determination and analysis, molecular modelling and structure simulation, overview
-
PROTEIN VARIANTS
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
D204A
almost complete loss of activity. Residue D204 is involved in the conformational change of the bound mannoside to a high-energy B2,5 conformation. In the mutant, mannose adopts the low-energy 4C1 conformation
D341N
D204A
mutant of Drosophila melanogaster, residual mannosidase activity
D341N
acid-base mutant, residual mannosidase activity
PURIFICATION (Commentary)
ORGANISM
UNIPROT
LITERATURE
method not mentioned
-
CLONED (Commentary)
ORGANISM
UNIPROT
LITERATURE
GmII is cloned, sequenced and localized to a single site, 85D14-18, on the right arm of chromosome 3
expressed in S2 insect cells
-
APPLICATION
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
drug development
the enzyme Golgi alpha-mannosidase II is a promising target for intervention in the glycosylation process
medicine
promising target for drug development in anti-tumor therapies, ability of seven available docking programs to predict the binding mode and binding affinity of alpha-mannosidase II inhibitors
drug development
-
development of specific inhibitors of GMII that can lead to novel anti-metastatic or anti-inflammatory compounds
REF.
AUTHORS
TITLE
JOURNAL
VOL.
PAGES
YEAR
ORGANISM (UNIPROT)
PUBMED ID
SOURCE
Shah, N.; Kuntz, D.A.; Rose, D.R.
Comparison of kifunensine and 1-deoxymannojirimycin binding to class I and II alpha-mannosidases demonstrates different saccharide distortions in inverting and retaining catalytic mechanisms
Biochemistry
42
13812-13816
2003
Drosophila melanogaster
Manually annotated by BRENDA team
Foster, J.M.; Yudkin, B.; Lockyer, A.E.; Roberts, D.B.
Cloning and sequence analysis of GmII, a Drosophila melanogaster homologue of the cDNA encoding murine Golgi alpha-mannosidase II
Gene
154
183-186
1995
Drosophila melanogaster (Q24451), Drosophila melanogaster, Mus musculus
Manually annotated by BRENDA team
Numao, S.; Kuntz, D.A.; Withers, S.G.; Rose, D.R.
Insights into the mechanism of Drosophila melanogaster Golgi alpha-mannosidase II through the structural analysis of covalent reaction intermediates
J. Biol. Chem.
278
48074-48083
2003
Drosophila melanogaster (Q24451)
Manually annotated by BRENDA team
Moremen, K.W.
Golgi alpha-mannosidase II deficiency in vertebrate systems: implications for asparagine-linked oligosaccharide processing in mammals
Biochim. Biophys. Acta
1573
225-235
2002
Drosophila melanogaster, Homo sapiens, Mus musculus, Rattus norvegicus
Manually annotated by BRENDA team
Kawatkar, S.P.; Kuntz, D.A.; Woods, R.J.; Rose, D.R.; Boons, G.J.
Structural basis of the inhibition of Golgi alpha-mannosidase II by mannostatin A and the role of the thiomethyl moiety in ligand-protein interactions
J. Am. Chem. Soc.
128
8310-8319
2006
Drosophila melanogaster
Manually annotated by BRENDA team
Kuntz, D.A.; Ghavami, A.; Johnston, B.D.; Pinto, B.M.; Rose, D.R.
Crystallographic analysis of the interactions of Drosophila melanogaster Golgi alpha-mannosidase II with the naturally occurring glycomimetic salacinol and its analogues
Tetrahedron Asymmetry
16
25-32
2005
Drosophila melanogaster (Q24451)
-
Manually annotated by BRENDA team
Kuntz, D.A.; Liu, H.; Bols, M.; Rose, D.R.
The role of the active site Zn in the catalytic mechanism of the GH38 Golgi alpha -mannosidase II: implications from noeuromycin inhibition
Biocatal. Biotransform.
24
55-61
2006
Drosophila melanogaster
-
Manually annotated by BRENDA team
Englebienne, P.; Fiaux, H.; Kuntz, D.A.; Corbeil, C.R.; Gerber-Lemaire, S.; Rose, D.R.; Moitessier, N.
Evaluation of docking programs for predicting binding of Golgi alpha-mannosidase II inhibitors: a comparison with crystallography
Proteins
69
160-176
2007
Drosophila melanogaster (Q24451)
Manually annotated by BRENDA team
Kumar, N.S.; Kuntz, D.A.; Wen, X.; Pinto, B.M.; Rose, D.R.
Binding of sulfonium-ion analogues of di-epi-swainsonine and 8-epi-lentiginosine to Drosophila Golgi alpha-mannosidase II: The role of water in inhibitor binding
Proteins
71
1484-1496
2008
Drosophila melanogaster (Q24451)
Manually annotated by BRENDA team
Kuntz, D.A.; Tarling, C.A.; Withers, S.G.; Rose, D.R.
Structural analysis of Golgi alpha-mannosidase II inhibitors identified from a focused glycosidase inhibitor screen
Biochemistry
47
10058-10068
2008
Drosophila melanogaster (Q24451)
Manually annotated by BRENDA team
Fiaux, H.; Kuntz, D.A.; Hoffman, D.; Janzer, R.C.; Gerber-Lemaire, S.; Rose, D.R.; Juillerat-Jeanneret, L.
Functionalized pyrrolidine inhibitors of human type II alpha-mannosidases as anti-cancer agents: optimizing the fit to the active site
Bioorg. Med. Chem.
16
7337-7346
2008
Canavalia ensiformis, Drosophila melanogaster, Drosophila melanogaster (Q24451), Homo sapiens
Manually annotated by BRENDA team
Kuntz, D.A.; Zhong, W.; Guo, J.; Rose, D.R.; Boons, G.J.
The molecular basis of inhibition of Golgi alpha-mannosidase II by mannostatin A
ChemBioChem
10
268-277
2009
Drosophila melanogaster, Drosophila melanogaster (Q24451)
Manually annotated by BRENDA team
Zhong, W.; Kuntz, D.A.; Ember, B.; Singh, H.; Moremen, K.W.; Rose, D.R.; Boons, G.J.
Probing the substrate specificity of Golgi alpha-mannosidase II by use of synthetic oligosaccharides and a catalytic nucleophile mutant
J. Am. Chem. Soc.
130
8975-8983
2008
Drosophila melanogaster, Drosophila melanogaster (Q24451)
Manually annotated by BRENDA team
Shah, N.; Kuntz, D.A.; Rose, D.R.
Golgi alpha-mannosidase II cleaves two sugars sequentially in the same catalytic site
Proc. Natl. Acad. Sci. USA
105
9570-9575
2008
Drosophila melanogaster (Q24451), Drosophila melanogaster
Manually annotated by BRENDA team
Kuntz, D.A.; Nakayama, S.; Shea, K.; Hori, H.; Uto, Y.; Nagasawa, H.; Rose, D.R.
Structural investigation of the binding of 5-substituted swainsonine analogues to Golgi alpha-mannosidase II
ChemBioChem
11
673-680
2010
Drosophila melanogaster (Q24451)
Manually annotated by BRENDA team
Petersen, L.; Ardevol, A.; Rovira, C.; Reilly, P.J.
Molecular mechanism of the glycosylation step catalyzed by Golgi alpha-mannosidase II: a QM/MM metadynamics investigation
J. Am. Chem. Soc.
132
8291-8300
2010
Drosophila melanogaster (Q24451)
Manually annotated by BRENDA team
Rose, D.R.
Structure, mechanism and inhibition of Golgi alpha-mannosidase II
Curr. Opin. Struct. Biol.
22
558-562
2012
Drosophila melanogaster
Manually annotated by BRENDA team